Showing results (1581-1590 of 1,799) with videos related to

Sort By:
Pageof 180
Mabs|December 23, 2014
Recombinant renewable polyclonal antibodiesFortunato Ferrara, Sara D'Angelo, Tiziano Gaiotto, et al.
Mabs|December 12, 2018
Effective binding to protein antigens by antibodies from antibody libraries designed with enhanced protein recognition propensitiesJhih-Wei Jian, Hong-Sen Chen, Yi-Kai Chiu, et al.
Mabs|December 14, 2018
Anti-PD1 'SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinementWilliam J J Finlay, James E Coleman, Jonathan S Edwards, et al.
Mabs|December 14, 2018
Structure, heterogeneity and developability assessment of therapeutic antibodiesYingda Xu, Dongdong Wang, Bruce Mason, et al.
Mabs|August 15, 2017
GingisKHAN™ protease cleavage allows a high-throughput antibody to Fab conversion enabling direct functional assessment during lead identification of human monoclonal and bispecific IgG1 antibodiesJörg Moelleken, Manuel Endesfelder, Christian Gassner, et al.
Mabs|November 1, 2019
NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodiesCorinna Lau, Martin Berner McAdam, Grethe Bergseth, et al.
Mabs|January 24, 2018
FcγRII-binding Centyrins mediate agonism and antibody-dependent cellular phagocytosis when fused to an anti-OX40 antibodyDi Zhang, Brian Whitaker, Mehabaw G Derebe, et al.
Mabs|January 30, 2018
A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody libraryAdam S Adler, Daniel Bedinger, Matthew S Adams, et al.
Mabs|January 31, 2018
Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatographyCher Hui Goey, David Bell, Cleo Kontoravdi
Mabs|February 2, 2018
Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined mediaJianlin Xu, Matthew S Rehmann, Xuankuo Xu, et al.
Pageof 180